FundedIQ
Artificial Intelligence

Sensydia: Funding, Investors & Team (Sep 2026)

Developer of a portable, point-of-care hemodynamic measurement platform that uses proprietary sensor technology and machine learning to guide critical patient management decisions in heart failure, sepsis, pulmonary hypertension, and other critical diseases. The Sensydia Cardiac Performance System™ (CPS) is entirely non-invasive, trained to gold standard, and can be deployed in minutes in the hospital, clinic, office or at home. By making hemodynamic insights as accessible as routine blood pressure readings, CPS will enable early disease detection and improve disease management through accurate, easy-to-use, non-invasive monitoring.

www.sensydia.com Los Angeles, United States 1-10 employees
Artificial Intelligence Health Care Medical Device Wearables Wireless B2B
Total raised
$8.0M
Rounds
1
Latest
Undisclosed round
May 2023

Sensydia has raised $8.0M across 1 funding round on record, the most recent an undisclosed round of $8.0M announced in May 2023.

That round is above the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.

Sensydia Company Profile and Key Stats

Total funding raised
$8.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$8.0M in May 2023
Employees
1-10
reported band
Headquarters
Los Angeles, United States

Latest funding round on record: May 2023.

Sensydia Funding Rounds

Date
Round
Amount
Undisclosed round
$8.0M

Sensydia Founders and Leadership Team

Name
Role
Contact
Xu Zhang
Founder
Locked

Contact details for the Sensydia team: 1 of 1 has an email address on file.

Start 14-day free trial →

Sensydia Funding Compared to Other Artificial Intelligence Startups

Segment
Companies
Median round

Sensydia's latest round of $8.0M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Sensydia in Artificial Intelligence and Los Angeles

Companies Similar to Sensydia

Series A $20.0M

Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…

Series E $156M

Instinct is an artificial intelligence startup developing AI technology.

Series B $250M

Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…

Undisclosed round $15.0M

Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…

Series A $8.0M

Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…

Series A $150M

Gatik, a new company, is creating technology for self-driving trucks that are used for short-distance…

Series D $200M

Generalist AI develops AI and robotics technologies focused on enabling robots to perform physical tasks in…

Series B $200M

Quintessent is a start-up in Santa Barbara that specializes in bringing quantum dot-based lasers and photonic…

Series A $40.0M

Contact: Cardiosense is building a physiological waveform data platform that leverages novel multi-modal…

Undisclosed round $26.1M

Thunder is a Cloud computing to democratize access to GPUs and solve the ongoing GPU shortage. Decentralized…

Series A $13.0M

Deepgram helps enterprises unlock the potential of their audio data with custom trained speech recognition…

Series C

Sensydia Funding FAQs

What does Sensydia do?

Developer of a portable, point-of-care hemodynamic measurement platform that uses proprietary sensor technology and machine learning to guide critical patient management decisions in heart failure, sepsis, pulmonary hypertension, and other critical diseases. The Sensydia Cardiac Performance System™ (CPS) is entirely non-invasive, trained to gold standard, and can be deployed in minutes in the hospital, clinic, office or at home. By making hemodynamic insights as accessible as routine blood pressure readings, CPS will enable early disease detection and improve disease management through accurate, easy-to-use, non-invasive monitoring.

How much funding has Sensydia raised?

Sensydia has raised $8.0M across 1 round on record. The most recent is an undisclosed round of $8.0M announced in May 2023.

When did Sensydia last raise funding?

Sensydia's most recent funding round on record is an undisclosed round of $8.0M, announced in May 2023.

Who founded Sensydia?

FundedIQ lists Xu Zhang (Founder) at Sensydia.

Where is Sensydia headquartered?

Sensydia is based in Los Angeles, California, United States.

How many employees does Sensydia have?

Sensydia is in the 1-10 employee band.

How does Sensydia's funding compare to other Artificial Intelligence startups?

Sensydia's latest round of $8.0M is above the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.

About FundedIQ's Sensydia Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sensydia is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.